Show simple item record

dc.contributor.authorKhan, I.
dc.contributor.authorRahman, L.
dc.contributor.authorMcKenna, D. B.
dc.date.accessioned2011-08-10T14:43:33Z
dc.date.available2011-08-10T14:43:33Z
dc.date.issued2009-06
dc.identifier.citationPrimary cutaneous melanoma: a complication of infliximab treatment? 2009, 34 (4):524 Clinical and Experimental Dermatologyen
dc.identifier.issn03076938
dc.identifier.issn13652230
dc.identifier.doi10.1111/j.1365-2230.2008.02970.x
dc.identifier.urihttp://hdl.handle.net/10147/139313
dc.descriptionA letter to the editor is presented which describes a patient with rheumatoid arthritis who developed malignant melanoma following infliximad therapy.en
dc.language.isoenen
dc.relation.urlhttp://doi.wiley.com/10.1111/j.1365-2230.2008.02970.xen
dc.subjectRHEUMATIC DISORDERen
dc.subjectARTHRITISen
dc.titlePrimary cutaneous melanoma: a complication of infliximab treatment?en
dc.typeArticleen
dc.identifier.journalClinical and Experimental Dermatologyen
dc.description.provinceConnacht


This item appears in the following Collection(s)

Show simple item record